NASDAQ Companies

EDISON, N.J., March 06, 2024 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on therapeutic […]

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based […]

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, […]

WOBURN, Mass., March 06, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, announced today […]

SEATTLE, March 06, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) announced today that data from the 40mg pharmacokinetic […]

BOSTON, March 06, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing […]

TAMPA, FL, March 06, 2024 (GLOBE NEWSWIRE) — TRxADE HEALTH Inc. (Nasdaq: MEDS) (the “Company”), announced that the Company’s board […]

CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying […]

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development […]

Reports Strong Financial Performance, Reiterates Plan for Organic Growth and Continued Debt Reduction in 2024 Forecasts Industry-Leading Bitcoin Mining Unit […]